View in browser

Header

Dear reader,

Drug discovery, metabolic analysis, Vitamin D testing – the range of applications for mass spectrometry pushes boundaries. The Covid pandemic lifts this to even greater heights – mass spec helps to predict infection severity, finds therapeutic targets and might even put an end to the unpleasant PCR nose-swab testing. 

Enjoy reading!

Advertisement
Advertisement

New gargle test

Mass spectrometry to improve Covid testing

A UK biotech laboratory has used mass spectrometry in a new approach to coronavirus testing. MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the current PCR (polymerase

Advertisement
Advertisement

Changes in cells caused by coronavirus

Potential targets for COVID-19 therapy discovered

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people. The scientists tested a series of

Clinical lab equipment

Why do Mass Spectrometers need to be Medical Devices?

Clinical biochemistry laboratories face many daily challenges, including managing high sample workloads, managing clinician requests for novel tests, and generating and reporting out results in a timely fashion. Irrespective of the methodology

Mass spectrometry-based metabolomics

A new technique to understand metabolic pathways

Mass spectrometry-based metabolomics has emerged as a powerful tool to help study chemical ecology. Recent advances in the technique make it possible to study microbial interactions from complex communities. Laia Castaño-Espriu outlined the role

Revealing innovation potential of new antibiotics

Using proteomic profiling to accelerate drug development

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents. The aim is to identify substances that attack the pathogens in a truly novel way. The team at the

Addressing a broad range of research applications

Mass spectrometry advances

Since the Covid-19 epidemic took hold, the public has expected ‘unprecedented progress from the scientific community,’ observed Dan Shine, senior vice president and president of the analytical instruments division of Thermo Fisher Scientific

Predictive proteins

Biomarkers in COVID-19 patients could predict how ill they become

Researchers at the Francis Crick Institute and Charité – Universitätsmedizin Berlin have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill with the disease. People

Please visit our mass spectrometry information channel!

 

You are receiving this email because you subscribed to our newsletter on healthcare-in-europe

If you don’t want to receive this newsletter anymore, click here to unsubscribe.

Keep up-to-date on the latest news from all hospital-related fields!
Subscribe to our bi-monthly newsletter.

Copyright © 2021 by European Hospital. All rights reserved.

EUROPEAN HOSPITAL Verlags GmbH
Theodor-Althoff-Str. 45, 45133 Essen, Germany

email: newsletter@european-hospital.com

Facebook
Twitter
RSS-Feed